The platelet to high density lipoprotein -cholesterol ratio is a valid biomarker of nascent metabolic syndrome.
Ishwarlal JialalGanesh JialalBeverley Adams-HuetPublished in: Diabetes/metabolism research and reviews (2020)
The ratio of platelets: HDL-C is significantly increased in patients with nascent MetS and appear to be a valid biomarker of MetS. It could also emerge as a biomarker for athero-thrombotic risk. However, these preliminary findings need confirmation in large prospective studies.